Cheng, et al. fused the splicing factor Fox1 element to dCas13d in order to inhibit Exon 7 skipping of SMN2 (Jillette and Cheng 2018), which gives new insights in SMA cures. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.